ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 190 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,197,122 | +122420.2% | 91,682 | +3.6% | 0.01% | +33.3% |
| Q3 2022 | $9,139 | +14.6% | 88,497 | +3.1% | 0.01% | +12.5% |
| Q2 2022 | $7,976 | -28.2% | 85,800 | -9.4% | 0.01% | 0.0% |
| Q1 2022 | $11,108 | -4.1% | 94,651 | +10.0% | 0.01% | +33.3% |
| Q4 2021 | $11,580 | -12.9% | 86,072 | +3.2% | 0.01% | -14.3% |
| Q3 2021 | $13,299 | +35.6% | 83,434 | +11.9% | 0.01% | +40.0% |
| Q2 2021 | $9,807 | -25.6% | 74,552 | -27.1% | 0.01% | -28.6% |
| Q1 2021 | $13,183 | +67.6% | 102,294 | +116.9% | 0.01% | +75.0% |
| Q4 2020 | $7,865 | – | 47,155 | – | 0.00% | – |
Download | ||||||